Skip to main content
. 2025 Apr 17;17(8):1348. doi: 10.3390/cancers17081348

Figure 3.

Figure 3

The OS of the selected 56 patients—infected group and non-infected age-matched case–control group—based on IDH mutation status (A), ATRX (B), and Ki-67 ratio (C). Kaplan–Meier functions show a significant difference of survival between patients with (red line) astrocytoma IDH-mutant CNS WHO grade 4 and without mutation (green line) glioblastoma IDH-wildtype CNS WHO grade 4 (A); ATRX negative (red line) and ATRX positive (green line) (B); Ki-67 ratio ≥ 30% (red line) and ≤30% (red line).